Risankizumab Safe, Effective for Long-Term Treatment of Crohn Disease
Investigators conducted an open-label extension to evaluate the long-term safety and efficacy of risankizumab for the treatment of moderate to severe Crohn disease.
Diagnosis & Disease Information
Perianal Crohn Disease Is a Strong Predictor of a Complicated Disease Course
Researchers evaluated perianal involvement in patients with CD and compared disease course in those with severe vs non-severe perianal CD.
Low FODMAP Diet and IBD: A Potential Option?
Current research indicates that short-term utilization of an LFD may help ameliorate some mild IBS symptoms associated with quiescent IBD, while further long term studies are still needed.
Marijuana and IBD: Challenging Decisions
Though patient use of cannabinoids for the treatment of IBD has increased, clinical decision making on whether to formally recommend it as treatment remains difficult.
Fecal DPP-4 Level May Be Biomarker for Inflammatory Bowel Disease
Researchers aimed to better elucidate the role of fDPP-4 levels as a biomarker of IBD activity and to correlate it with certain clinical parameters.
HIV and Inflammatory Bowel Disease: A Unique Patient Population
The authors review gut dysfunction and microbiota changes during HIV infection and IBD and discuss how they may induce a dysfunctional mucosal barrier, dysbiosis, and changes on the cellular level, including monocytes, macrophages, and dendritic cells.
Disparities in the Diagnosis and Management of IBD Among Different Racial and Ethnic Groups
Researchers sought to identify disparities in the care and outcomes of patients with IBD of differing races and ethnicities, in order to improve health care equity.
- Loading...
Loading...
Loading... 
Loading...